These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma. Yang XR, Xu Y, Yu B, Zhou J, Qiu SJ, Shi GM, Zhang BH, Wu WZ, Shi YH, Wu B, Yang GH, Ji Y, Fan J. Gut; 2010 Jul; 59(7):953-62. PubMed ID: 20442200 [Abstract] [Full Text] [Related]
9. Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients. Tseng PL, Tai MH, Huang CC, Wang CC, Lin JW, Hung CH, Chen CH, Wang JH, Lu SN, Lee CM, Changchien CS, Hu TH. J Surg Oncol; 2008 Oct 01; 98(5):349-57. PubMed ID: 18646041 [Abstract] [Full Text] [Related]
11. Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma. Poon RT, Lau CP, Ho JW, Yu WC, Fan ST, Wong J. Clin Cancer Res; 2003 Nov 01; 9(14):5339-45. PubMed ID: 14614019 [Abstract] [Full Text] [Related]
17. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma. Fang F, Luo LB, Tao YM, Wu F, Yang LY. Cancer Epidemiol Biomarkers Prev; 2009 Feb 01; 18(2):409-16. PubMed ID: 19208663 [Abstract] [Full Text] [Related]